Literature DB >> 17363563

Characterization of microRNA expression levels and their biological correlates in human cancer cell lines.

Arti Gaur1, David A Jewell, Yu Liang, Dana Ridzon, Jason H Moore, Caifu Chen, Victor R Ambros, Mark A Israel.   

Abstract

MicroRNAs are small noncoding RNAs that function by regulating target gene expression posttranscriptionally. They play a critical role in developmental and physiologic processes and are implicated in the pathogenesis of several human diseases including cancer. We examined the expression profiles of 241 human microRNAs in normal tissues and the NCI-60 panel of human tumor-derived cell lines. To quantify microRNA expression, we employed a highly sensitive technique that uses stem-loop primers for reverse transcription followed by real-time PCR. Most microRNAs were expressed at lower levels in tumor-derived cell lines compared with the corresponding normal tissue. Agglomerative hierarchical clustering analysis of microRNA expression revealed four groups among the NCI-60 cell lines consisting of hematologic, colon, central nervous system, and melanoma tumor-derived cell lines clustered in a manner that reflected their tissue of origin. We identified specific subsets of microRNAs that provide candidate molecular signatures characteristic of the tumor-derived cell lines belonging to these four clusters. We also identified specific microRNA expression patterns that correlated with the proliferation indices of the NCI-60 cell lines, and we developed evidence for the identification of specific microRNAs as candidate oncogenes and tumor suppressor genes in different tumor types. Our results provide evidence that microRNA expression patterns may mark specific biological characteristics of tumors and/or mediate biological activities important for the pathobiology of malignant tumors. These findings call attention to the potential of microRNAs to provide etiologic insights as well as to serve as both diagnostic markers and therapeutic targets for many different tumor types.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17363563     DOI: 10.1158/0008-5472.CAN-06-2698

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  315 in total

1.  Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo.

Authors:  Arti B Gaur; Susan L Holbeck; Nancy H Colburn; Mark A Israel
Journal:  Neuro Oncol       Date:  2011-06       Impact factor: 12.300

Review 2.  Micro-RNAs and breast cancer.

Authors:  John Le Quesne; Carlos Caldas
Journal:  Mol Oncol       Date:  2010-04-28       Impact factor: 6.603

3.  mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities.

Authors:  Hongfang Liu; Petula D'Andrade; Stephanie Fulmer-Smentek; Philip Lorenzi; Kurt W Kohn; John N Weinstein; Yves Pommier; William C Reinhold
Journal:  Mol Cancer Ther       Date:  2010-05-04       Impact factor: 6.261

Review 4.  MicroRNAs in skin and wound healing.

Authors:  Jaideep Banerjee; Yuk Cheung Chan; Chandan K Sen
Journal:  Physiol Genomics       Date:  2010-10-19       Impact factor: 3.107

5.  Olea europaea leaf extract alters microRNA expression in human glioblastoma cells.

Authors:  Berrin Tunca; Gulcin Tezcan; Gulsah Cecener; Unal Egeli; Secil Ak; Hulusi Malyer; Gulendam Tumen; Ayhan Bilir
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-22       Impact factor: 4.553

6.  The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma.

Authors:  Xiaofang Guo; Qianjin Liao; Pan Chen; Xiayu Li; Wei Xiong; Jian Ma; Xiaoling Li; Zhaohui Luo; Hailin Tang; Min Deng; Yin Zheng; Rong Wang; Wenling Zhang; Guiyuan Li
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-28       Impact factor: 4.553

Review 7.  Cross talk between microRNA and coding cancer genes.

Authors:  Tanja Kunej; Irena Godnic; Simon Horvat; Minja Zorc; George A Calin
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

8.  Effects of oestrogen on microRNA expression in hormone-responsive breast cancer cells.

Authors:  Lorenzo Ferraro; Maria Ravo; Giovanni Nassa; Roberta Tarallo; Maria Rosaria De Filippo; Giorgio Giurato; Francesca Cirillo; Claudia Stellato; Silvana Silvestro; Concita Cantarella; Francesca Rizzo; Daniela Cimino; Olivier Friard; Nicoletta Biglia; Michele De Bortoli; Luigi Cicatiello; Ernesto Nola; Alessandro Weisz
Journal:  Horm Cancer       Date:  2012-06       Impact factor: 3.869

Review 9.  The use of genomic information to optimize cancer chemotherapy.

Authors:  Federico Innocenti; Nancy J Cox; M Eileen Dolan
Journal:  Semin Oncol       Date:  2011-04       Impact factor: 4.929

Review 10.  MicroRNAs in cancer.

Authors:  Yong Sun Lee; Anindya Dutta
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.